The FDA withdraws metformin for treating diabetes … Know the reason

Thank you for reading a story about the New York Post: The FDA is withdrawing metformin for treating diabetes … Know the reason, and now with the details of the news

Cairo – by Mohamed Salah – The US Food and Drug Administration announced FDA This week, the diabetes drug metformin hydrochloride was withdrawn because it contains excessive levels of the carcinogen.

According to a report by the American “New York Post”, the company Marksans Pharma Limited The drug manufacturer is expanding the recall that was initially announced in June to now include 76 additional quantities of expired drugs, as the recalled drugs are marketed as “extended-release tablets” under the brand name. Time-Cap Labs، Inc.


Withdrawal of a sugar medicine containing carcinogens

The drug helps lower blood glucose levels in patients with type 2 diabetes, but the recalled product contains an unacceptably high level of the substance N-Nitrosodimethylamine , Which is considered a possible human carcinogen.

Advertisements

The Food and Drug Administration stated in its advertisement, “The company has leased Marksans Exam N-Nitrosodimethylamine (NDMA) For unfinished marketed pieces specified and noted material content NDMA (In some parts, the acceptable daily intake is exceeded)NAME) Of 96 ng / day, therefore, out of extreme caution, an additional 76 pieces were withdrawn.

Recalling applies to metformin tablets between 500 mg and 750 mg, and tablets of 500 mg with “101” inscribed on one side.

8a29a550c4.jpg

The Food and Drug Administration advises (FDAThe users continue to take the withdrawn tablets until a medical professional provides an alternative or alternative treatment option.

“It may be dangerous for people with type 2 diabetes to stop taking metformin without first talking to a healthcare professional,” the Food and Drug Administration said in a statement.

Consumers should “contact their physician or health care provider if they encounter any problems that may be related to the intake or use of this medicinal product.”

These were the details of the New York Post news: The FDA is withdrawing the drug metformin for treating diabetes..I know the reason for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available on the seventh day The editorial team has done Gulf 365 By making sure of it, and it may have been modified, and it may have been completely transferred or quoted from it, and you can read and follow this news from its main source.

These were the details of the news The FDA withdraws metformin for treating diabetes … Know the reason for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT Kremlin says West’s sanctions don’t work, vows response